[1]Patent:WO2013/4984,2013,A1.Locationinpatent:Page/Pagecolumn72
[1]Patent:WO2016/145383,2016,A1.Locationinpatent:Paragraph0183
[1]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.1503-1507
1016232-92-0
1458653-12-7
1499172-23-4
2893-65-4
622-93-5
42055-16-3
1612176-00-7 | Cis-3-fluoro-4-hydroxy-5,5-dimethylpiperidine-1-carboxylic acid tert-butyl ester | AA001S6O | MFCD27988130
16200-50-3 | 3,4-Diethyl-2-ethoxycarbonyl-5-methylpyrrole | AA001SIY | MFCD00075089
1621961-57-6 | (S)-5-Oxopiperazine-2-carboxylic acid hydrochloride | AA001SS1 | MFCD28044202
16251-45-9 | (4S,5R)-(-)-4-Methyl-5-phenyl-2-oxazolidinone | AA001T4O | MFCD00066226
87977-27-3 | 3-Pyridazinemethanamine, 6-(4-morpholinyl)-, hydrochloride (1:1) | AA01X51B | MFCD28134597
16313-77-2 | 2-Methoxy-3,5-dimethylbenzaldehyde | AA001TQ7 | MFCD06247962
163457-23-6 | 3,3-Difluoropyrrolidine, HCl | AA001U27 | MFCD03788948
1638-86-4 | Diethyl phenylphosphonite | AA001UC7 | MFCD00009086
16423-51-1 | N,N-Di-n-hexylacetamide | AA001UNP | MFCD00082658
1646152-49-9 | 2-(Bromomethyl)-5-chloropyridine hydrobromide | AA001UWU | MFCD20527163